Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (Leukemia, (2019), 33, 8, (1910-1922), 10.1038/s41375-019-0413-0)

Pfeifer H., Cazzaniga G., van der Velden VHJ., Cayuela JM., Schäfer B., Spinelli O., Akiki S., Avigad S., Bendit I., Borg K., Cavé H., Elia L., Reshmi SC., Gerrard G., Hayette S., Hermanson M., Juh A., Jurcek T., Chillón MC., Homburg C., Martinelli G., Kairisto V., Lange T., Lion T., Mueller MC., Pane F., Rai L., Damm-Welk C., Sacha T., Schnittger S., Touloumenidou T., Valerhaugen H., Vandenberghe P., Zuna J., Serve H., Herrmann E., Markovic S., van Dongen JJM., Ottmann OG.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

DOI

10.1038/s41375-020-0707-2

Type

Journal article

Journal

Leukemia

Publication Date

01/07/2020

Volume

34

Permalink Original publication